SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 21, 2004
RESPIRONICS, INC.
(Exact name of Registrant as specified in its charter)
| Delaware | 000-16723 | 25-1304989 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
||
| 1010 Murry Ridge Lane Murrysville, Pennsylvania |
15668-8525 |
|||
| (Address of Principal Executive Offices) |
(Zip Code) |
724-387-5200
TABLE OF CONTENTS
| Page | ||||
| 2 | ||||
| 3 | ||||
| 4 | ||||
Item 2.02. DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On October 21, 2004, Respironics Inc. issued a press release announcing its financial results for the three months ended September 30, 2004. A copy of the press release is attached hereto as Exhibit 99.
Exhibits
99 Press release, dated October 21, 2004, issued by Respironics, Inc.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| RESPIRONICS, INC. | ||||||
| By: | /s/ Daniel J. Bevevino Daniel J. Bevevino Vice President, and Chief Financial and Principal Accounting Officer |
|||||
Dated: October 21, 2004
3